• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Five Ways to Enhance Clinical Operational Efficiencies Utilizing AI

    Transitioning from Clinical Production to Commercial Manufacturing

    Clinical Trial Technology

    Regenerative Medicine: Overcoming the supply chain challenges

    The Future of the Pharmaceutical Supply Chain
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Sanofi Awarded $226M by US Gov't for Pandemic Influenza Preparedness

    Amgen Selects Location For R&D Facility

    Arctoris Opens Oxford R&D Facility

    Almac Group, Exostar Collaborate on IRT Experience

    Northwest Biotherapeutics Expands Management Team
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Amgen Selects Location For R&D Facility

    Catalent Launches Clinical Trial Planning Service

    CatSci Expands Capabilities with Lab Expansion

    PCI Pharma Services Invests in Tredegar, UK Site

    Avantor Boosts Biopharmaceutical Innovation in China
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Smart Tags on Pills Set to Improve Supply Chain Security and Patient Adherence

    Schreiner MediPharm, PragmatIC Form Partnership for Smart Pharma Labels

    Stevanato Group Begins Construction on TEC

    CSafe Global Expands Packaging Portfolio

    CSafe Global Opens Service Centers in Switzerland and Sweden
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Sanofi Awarded $226M by US Gov't for Pandemic Influenza Preparedness

    Amgen Selects Location For R&D Facility

    Arctoris Opens Oxford R&D Facility

    Almac Group, Exostar Collaborate on IRT Experience

    Charles River Provides Access to Cosmic Antibody Library
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Pelican BioThermal Achieves ISO Accreditation

    PhRMA Appoints Federal Advocacy SVP

    CureVac Granted Mfg. Authorization for GMP Production Suite

    Metrics Completes Japanese Regulatory Inspection

    Samsung Biologics Achieves ISO27001 Certification
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Ajinomoto Bio-Pharma Services

    Flow Sciences, Inc.

    Baxter BioPharma Solutions

    Alcami

    CCRM
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Aphena Pharma Solutions, Inc.

    Reed-Lane, Inc.

    CCRM

    Baxter BioPharma Solutions

    Jubilant HollisterStier Contract Manufacturing & Services
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
      • Top 20 Pharma & BioPharma
      • Top 10 BioPharma Companies
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • Podcasts
    • White Papers
    • Infographics
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Agenda
      • Conference Sessions
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Breaking News

    IONTAS, Adaptate Enter Antibodies Alliance

    To generate and optimize antibodies for novel immuno-oncology targets

    Related CONTENT
    • Telix, Eczacıbaşı-Monrol Sign Manufacturing Agreement
    • Avomeen Appoints Head of Elemental Analysis
    • Gilead Appoints CEO of Kite
    • Mereo BioPharma Appoints Head of Pharma Development
    • Goodwin Biotechnology Bolsters Quality & Regulatory Capabilities
    12.03.19
    IONTAS Ltd. has entered a collaboration with Adaptate Biotherapeutics, a developer of antibody-based therapeutics for modulation of gamma delta T-cells, to generate and optimize antibodies for novel immuno-oncology targets, including IONTAS’ Mammalian Display technology to select antibodies with optimal biophysical properties.
     
    IONTAS’ technology enables the construction of large libraries of stable cell lines displaying human antibodies on their surface. The technology also addresses “developability” issues early in discovery, increasing the likelihood of successful progress through the development process. Under the collaboration, Adaptate Biotherapeutics has access to IONTAS’ Mammalian Display technology, allowing the selection of high affinity antibodies based on their function, stability, expression and developability, helping to facilitate a faster transition through Chemistry, Manufacturing and Controls (CMC) and eventual manufacturing. 
     
    Dr. John McCafferty, founder and chief executive officer of IONTAS, said, “Recently spun out of GammaDelta Therapeutics, Adaptate Biotherapeutics is already a leading company in the field of gamma delta T cell therapeutics and it is a privilege to be working with such an innovative team. This collaboration is further validation of our platform, including our Mammalian Display technology, and adds to an expanding portfolio of partners that enjoy the benefit of combining selection for affinity with developability during the initial steps of drug discovery. Subsequently, the resulting panels of “developable” antibodies facilitate manufacture and reduce the risk of delays and potential product failure by detecting and avoiding problematic clones at the outset. Our aim is to ensure the right lead is selected first time, every time.” 
     
    Dr. Natalie Mount, chief executive officer of Adaptate Biotherapeutics, said, “IONTAS has developed an impressive track record in delivering therapeutic antibodies. We selected them as our partner because of their extensive experience in overcoming antibody project challenges using their industry-leading platforms. We anticipate that the combination of IONTAS’ antibody discovery capabilities and our innovative approach to gamma delta T cell-targeted therapeutics will facilitate the accelerated entry of our oncology portfolio to the clinic.”
    Related Searches
    • CMC
    • Stability
    • collaboration
    • Validation
    Suggested For You
    Entera Bio Establishes U.S. HQ in Wellesley, MA Entera Bio Establishes U.S. HQ in Wellesley, MA
    Frontage Laboratories, Inc. Frontage Laboratories, Inc.
    Deriving Value from Integrated cGMP and Pre-GMP Manufacturing Operations Deriving Value from Integrated cGMP and Pre-GMP Manufacturing Operations
    Flamma Arrives in the U.S. Flamma Arrives in the U.S.
    Tedor, Sequential Enter Clinical Manufacturing Pact Tedor, Sequential Enter Clinical Manufacturing Pact
    CMAB Biopharma, BJ Bioscience in Strategic Development and Mfg. Pact CMAB Biopharma, BJ Bioscience in Strategic Development and Mfg. Pact
    Rentschler Expands Collaboration with Summit Rentschler Expands Collaboration with Summit
    Avidity Biosciences Appoints President and CEO Avidity Biosciences Appoints President and CEO
    Almac Discovery Appoints BD VP Almac Discovery Appoints BD VP
    Jubilant Therapeutics Appoints President and CEO Jubilant Therapeutics Appoints President and CEO
    Atlasciences Appoints Chief Scientific Officer Atlasciences Appoints Chief Scientific Officer
    Goodwin Biotechnology Bolsters Quality & Regulatory Capabilities Goodwin Biotechnology Bolsters Quality & Regulatory Capabilities
    Mereo BioPharma Appoints Head of Pharma Development Mereo BioPharma Appoints Head of Pharma Development
    Gilead Appoints CEO of Kite Gilead Appoints CEO of Kite
    Avomeen Appoints Head of Elemental Analysis Avomeen Appoints Head of Elemental Analysis

    Related Breaking News

    • Bioanalytical Services | Breaking News | Drug Discovery | Industry News | R&D
      Arctoris Opens Oxford R&D Facility

      Arctoris Opens Oxford R&D Facility

      Houses next-gen, fully automated platform that generates reproducible data from biochemical, cell-based molecular biology assays
      12.12.19

    • Breaking News | Drug Discovery | Industry News | Preclinical Outsourcing
      Charles River Provides Access to Cosmic Antibody Library

      Charles River Provides Access to Cosmic Antibody Library

      Expanded antibody library launched by Distributed Bio aims to expedite the drug discovery process
      12.12.19

    • Biologics, Proteins, Vaccines | Breaking News | CRO News | Drug Discovery
      Charles River, Bit Bio Enter Strategic Pact

      Charles River, Bit Bio Enter Strategic Pact

      Partnership will leverage Bit Bio’s unique ability to generate authentic human cells at scale
      12.10.19


    • Bio News | Breaking News | Drug Discovery | Facilities | Industry News
      Jubilant Biosys Expands Discovery Capabilities

      Jubilant Biosys Expands Discovery Capabilities

      Begins major capacity expansions for its drug discovery services business.
      12.09.19

    • Breaking News | Collaborations & Alliances | Drug Development | Drug Discovery
      Evotec, Celmatix Expand Strategic Pact

      Evotec, Celmatix Expand Strategic Pact

      To collaborate to develop preclinical programs for highly prevalent, yet underserved conditions affecting women's reproductive health
      12.03.19

    • Breaking News | Drug Development | Drug Discovery | Industry News
      Lilly Opens Shared Innovation Lab

      Lilly Opens Shared Innovation Lab

      Aims to speed the discovery of innovative medicines through collaboration with local biotech companies
      12.02.19


    • Breaking News | Collaborations & Alliances | Drug Development | Drug Discovery
      Harpoon, Abbvie Expand Immunotherapy Alliance

      Harpoon, Abbvie Expand Immunotherapy Alliance

      New license and option agreement represents a potential transaction value of as much as $510 million
      11.21.19

    • Breaking News | CRO News | Drug Development | Drug Discovery | Industry News | R&D
      BASi Launches CRO Rebrand

      BASi Launches CRO Rebrand

      Inotiv is the new name of its contract research services business.
      11.20.19

    • Bio News | Breaking News | Collaborations & Alliances | Drug Discovery | Industry News
      BioDuro Chooses SciFinder-n From CAS

      BioDuro Chooses SciFinder-n From CAS

      Enhances research productivity and shortens cycle times for clients.
      11.18.19


    • Collaborations & Alliances | Drug Development | Drug Discovery
      Bayer, Dewpoint Ink Research and License Agreement

      Bayer, Dewpoint Ink Research and License Agreement

      Will leverage Dewpoint's platform for biomolecular condensates and Bayer's small molecule compound library to develop new treatments
      11.14.19

    • Drug Development | Drug Discovery
      Recipharm Joins AMR Industry Alliance

      Recipharm Joins AMR Industry Alliance

      Aims to address growing concerns around antimicrobial resistance.
      11.14.19

    • Drug Development | Drug Discovery | Industry News
      MilliporeSigma Licenses CRISPR Technology to Evotec

      MilliporeSigma Licenses CRISPR Technology to Evotec

      Will leverage CRISPR Portfolio to develop precisely engineered assays for potential drug candidates during the drug development cycle
      11.12.19

    • Bio News | Bioassay Development | Breaking News | Collaborations & Alliances | Drug Discovery | Industry News
      Eurofins Discovery and Escient Form Collaboration

      Eurofins Discovery and Escient Form Collaboration

      Eurofins to provide assay development and drug discovery services.
      10.28.19

    • Breaking News | Drug Discovery | Industry News | Preclinical Outsourcing
      BioIVT Acquires PPA Research Group

      BioIVT Acquires PPA Research Group

      Expands product portfolio to support immuno-oncology and cell therapy research
      10.18.19

    • cGMP Manufacture | Collaborations & Alliances | Drug Development | Drug Discovery
      Shionogi & Co., Hsiri Therapeutics Expand Infectious Diseases Alliance

      Shionogi & Co., Hsiri Therapeutics Expand Infectious Diseases Alliance

      Shionogi will have exclusive worldwide rights to develop, manufacture, and commercialize the compounds generated from the collaboration
      10.11.19

    Breaking News
    • Sanofi Awarded $226M by US Gov't for Pandemic Influenza Preparedness
    • Amgen Selects Location For R&D Facility
    • Arctoris Opens Oxford R&D Facility
    • Almac Group, Exostar Collaborate on IRT Experience
    • Northwest Biotherapeutics Expands Management Team
    View Breaking News >
    CURRENT ISSUE

    November/December 2019

    • Five Ways to Enhance Clinical Operational Efficiencies Utilizing AI
    • Transitioning from Clinical Production to Commercial Manufacturing
    • Clinical Trial Technology
    • Regenerative Medicine: Overcoming the supply chain challenges
    • The Future of the Pharmaceutical Supply Chain
    • Challenges and Opportunities in Vaccines Drug Development
    • Managing Partnerships: Sponsors & CDMOs
    • Towards Sunset or a New Dawn?
    • Biopharma Over 20 Years
    • View More >
    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Deerland Obtains Certification from Australia’s Therapeutic Goods Administration
    OptiMSM Shown to Improve Hair & Nail Appearance and Condition
    DCC Acquires Contract Manufacturer Ion Laboratories
    Coatings World

    Latest Breaking News From Coatings World

    Arkema: Bostik Acquires Danish Company LIP
    Axalta Adds New Epoxy Primer to Tufcote Liquid Industrial Coatings Portfolio
    Chromaflo Technologies Promotes Sergio Duenas to Country Manager of Mexico
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    FDA OKs World's First Single-Use Duodenoscope
    Dr. Stephen Hahn Confirmed as New FDA Leader
    FDA OKs First Test to Help Screen for Newborn Duchenne Muscular Dystrophy
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Sanofi Awarded $226M by US Gov't for Pandemic Influenza Preparedness
    Amgen Selects Location For R&D Facility
    Arctoris Opens Oxford R&D Facility
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Time Features 5 Best Beauty Inventions
    CES 2020 Preview - Innovation Award Honorees in Health & Wellness
    Prada & L’Oréal Sign Long-Term Licensing Deal
    Happi

    Latest Breaking News From Happi

    Cosmetic Assessments Revealed at CIR Panel
    T-Boz Launches CBD Line
    DRF and Flowerkist Develop CBD Range
    Ink World

    Latest Breaking News From Ink World

    Ripon Printers Adds Ricoh Pro C9210
    LogoJet Opens Bogota, Colombia Office
    Canon Solutions America Powers University of Notre Dame Athletics' Printing Capabilities
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    GSE products provide quality assurance for Pharmalabel
    Luminer promotes Heather Bookman to prepress manager
    Materials Exchange launches to solve excess inventory issue
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    DuPont to Acquire Osmosis Specialist
    Nice-Pak to Expand in Indiana
    Hospeco Launches Compact Fem Hy Dispenser
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    FDA OKs First Test to Help Screen for Newborn Duchenne Muscular Dystrophy
    Europe, North America Comprise More Than 80 Percent of Global Bone Marrow Transplantation Demand
    TriMed Closes Out FDA Warning Letter
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    3D Printing Materials Market to Grow at 23.9% CAGR Through 2025: GVR
    Kyocera, TactoTek Collaborate on Injection Molded Structural Electronics Solutions
    Toray Opens R&D Innovation Center for the Future

    Copyright © 2019 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.